MRI Breast Without and With IV Contrast Although there may be residual breast glandular tissue after mastectomy and MRI may be useful in delineating the amount of this residual tissue in women after prophylactic mastectomy [35], there is insufficient evidence to support the use of MRI breast without and with IV contrast for breast cancer screening in this population. A small retrospective study of breast MRI surveillance examinations performed in a subset of women who underwent bilateral mastectomy for either cancer or prophylaxis and had either implant, flap, or mixed reconstructions found no cancers that were not also evident on clinical examinations [33]. Sestamibi MBI There is no relevant literature to support the use of Tc-99m sestamibi MBI for screening in this clinical setting. US Breast There is no relevant literature to support the use of US for screening in this clinical setting. Digital Breast Tomosynthesis Screening There is no relevant literature to support the use of DBT for screening in this clinical setting. Mammography Screening There is no relevant literature to support the use of mammography for screening in this clinical setting. FDG-PET Breast Dedicated There is no relevant literature to support the use of FDG-PET breast for screening in this clinical setting. MRI Breast Without IV Contrast There is no relevant literature to support the use of MRI without IV contrast for screening in this clinical setting. MRI Breast Without and With IV Contrast There is insufficient evidence to support screening for women with prophylactic mastectomy and implant reconstruction. It has been suggested that the yield of screening in this setting is especially low in the setting of retropectoral implant placement, in which recurrences are most likely to be clinically palpable [33,34].
Imaging after Mastectomy and Breast Reconstruction. MRI Breast Without and With IV Contrast Although there may be residual breast glandular tissue after mastectomy and MRI may be useful in delineating the amount of this residual tissue in women after prophylactic mastectomy [35], there is insufficient evidence to support the use of MRI breast without and with IV contrast for breast cancer screening in this population. A small retrospective study of breast MRI surveillance examinations performed in a subset of women who underwent bilateral mastectomy for either cancer or prophylaxis and had either implant, flap, or mixed reconstructions found no cancers that were not also evident on clinical examinations [33]. Sestamibi MBI There is no relevant literature to support the use of Tc-99m sestamibi MBI for screening in this clinical setting. US Breast There is no relevant literature to support the use of US for screening in this clinical setting. Digital Breast Tomosynthesis Screening There is no relevant literature to support the use of DBT for screening in this clinical setting. Mammography Screening There is no relevant literature to support the use of mammography for screening in this clinical setting. FDG-PET Breast Dedicated There is no relevant literature to support the use of FDG-PET breast for screening in this clinical setting. MRI Breast Without IV Contrast There is no relevant literature to support the use of MRI without IV contrast for screening in this clinical setting. MRI Breast Without and With IV Contrast There is insufficient evidence to support screening for women with prophylactic mastectomy and implant reconstruction. It has been suggested that the yield of screening in this setting is especially low in the setting of retropectoral implant placement, in which recurrences are most likely to be clinically palpable [33,34].